Industries > Pharma > Global Ablation Technologies Market Forecast 2019-2029

Global Ablation Technologies Market Forecast 2019-2029

Cryoablation, Electrical, Endometrial Hydrothermal, Laser/Light, Microwave, Radiofrequency, Ultrasound, Cardiovascular, Gynaecology, Musculoskeletal, Ophthalmology, Urology

PAGES: 212
PRODUCT CODE: PHA0385
SUBMARKET: Medical Devices

Clear
WOOCS 2.2.1
SKU: PHA0385 Categories: , Tags: ,

The global ablation technologies market is expected to grow at a CAGR of 9.4% from 2017-2022 and CAGR of 9.7% from 2022-2027. The market is expected to grow at a CAGR of 9.5% from 2017 to 2027. The market is estimated at $3.3bn in 2016, and $9.05bn in 2026.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 212-page report you will receive 92 tables and 190 figures – all unavailable elsewhere.

The 212-page report provides clear detailed insight into the Global Ablation Technologies market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand new report today you stay better informed and ready to act.

Report Scope
• Revenue and growth forecasts to 2027 for the global ablation technologies market
• Revenue and growth forecasts to 2027 for the leading countries
• Revenue and growth forecasts to 2027 for the leading segments of the global ablation technologies market by technology and application.
• Revenue and growth forecasts to 2027 for the leading companies

Global Ablation Technologies Market Forecast 2019-2029

Individual revenue forecasts to 2027 by technology, each submarket is further segmented by geography (North America, Europe, Asia-Pacific, and RoW):
• Radiofrequency
• Ultrasound
• Cyroablation
• Endometrial Hydrothermal
• Laser/light
• Electrical
• Microwave

Individual revenue forecasts to 2027 by application, each submarket is further segmented by geography (North America, Europe, Asia-Pacific, and RoW):
• Cardiovascular
• Oncology
• Musculoskeletal
• Ophthalmology
• Gynaecology
• Urology
• Other

Individual revenue forecasts to 2027 by country, each country is further segmented by technology:
• United States
• Canada
• Germany
• France
• United Kingdom
• Italy
• Spain
• Japan
• China
• India
• Rest of APAC
• Rest of the World

Discussion and revenue forecasts to 2027 of the major players in the ablation technologies market:
• Medtronic Plc
• Biosense Water, Inc./Johnson & Johnson, Inc.
• St. Jude Medical, Inc.
• Boston Scientific Corporation
• Angiodynamics, Inc.
• Atricure, Inc.
• Conmed Corporation
• Olympus Corporation
• Smith & Nephew

Visiongain’s study is intended for anyone requiring commercial analyses for the Ablation Technologies market. You find data, trends and predictions.

Buy our report today Global Ablation Technologies Market Forecast 2019-2029: Cryoablation, Electrical, Endometrial Hydrothermal, Laser/Light, Microwave, Radiofrequency, Ultrasound, Cardiovascular, Gynaecology, Musculoskeletal, Ophthalmology, Urology.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for Global Ablation Technologies Market Forecast 2019-2029


Download sample pages

Complete the form below to download your free sample pages for Global Ablation Technologies Market Forecast 2019-2029


Latest Pharma news

Visiongain Publishes Generic Drugs Market Report 2020-2030

The 431-page report provides clear detailed insight into the generic drugs market. Discover the key drivers and challenges affecting the market.

03 July 2020

READ

Visiongain publishes Clinical Workflow Solutions Market Report 2020-2030

Where is the Clinical Workflow Solutions market heading? If you are involved in this sector you must read this newly updated report. Visiongain’s report shows you the potential revenues streams to 2030, assessing data, trends, opportunities and business prospects there.

03 July 2020

READ

Visiongain Publishes Clinical Trials Market Report 2020-2030

With the growing burden of rare diseases around the world, there has been a rise and advancement in the therapy development of these types of diseases. While the fact remains that over 90% of these diseases lack approval for treatment and the total number of terminal rare diseases to receive the first treatment every year remains low.

01 July 2020

READ

Visiongain Publishes Clinical Risk Grouping Solutions Market Report 2020-2030

The market growth is attributed to the growing adoption of big data and AI in data management and monitoring of clinical information in health care.

01 July 2020

READ

Categories

Category